Imutex

Imutex is a medical company that developed an IIa-ready universal flu vaccine in England to prevent infections. Founded 2016 in London, England, United Kingdom, Imutex Limited is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine. The company is a developer of vaccines against influenza (flu) and mosquito-borne diseases, such as flu, zika, and other flaviviruses. It engages in the research and development of a vaccine that has proposed a dual action mechanism, aiming to prevent infection in humans and also to control the mosquito population.